🌍 Demo Day: Investing Beyond Borders 🌍
​Sign up and join us at this online event, where we will show you some of the best European investment opportunities in biotech, healthtech, and life science.
​AGENDA
​18:00h - 18:05h | Welcome to Attendees
​18:05h - 18:10h | Presentation & Introductions
Daniel Oliver, CEO of Capital Cell, will host the event alongside key European players in the biotech investment sector.
​18:10h - 18:30h | Panel discussion: "Barriers to Biotech Investment in Europe: An Investor's Perspective", with Joël Jean-Mairet, Partner at Ysios Capital, Joana Cartocci, BoD Member at France Biotech; and Montserrat Corominas, Founder & CEO at Intergroup Partners.
In this round table, we will talk about the limitations and the opportunities in European biotech funding, covering cross-border investment, the impact of entrepreneurial culture, and regulatory constraints.
​18:30h - 19:10h | Pitch to Investors
Each company will have 5 minutes to present their innovations!
​OxyPrem: Premature babies are the most fragile patients. Just 5' of harmful oxygen levels can cause life-long brain damage. OxyPrem's cerebral oxygen sensors help medical teams to react in time before damage occurs.
​Verigraft: The company’s unique technology platform turns donated allogeneic (“foreign”) tissue into an autologous-like (“personalized”) tissue and thus avoids transplant rejection and the need for life-long immunosuppression.
​Arjuna: It first drug, Ag5, aims to redefine the treatment landscape for solid tumours on both sides of the blood brain barrier by targeting the 30% of all cancers that generate high levels of Reactive Oxygen Species.
​U-care: Clinical-AI platform designed to predict and support the management of critical-care complications, improving quality of care and efficiency in Intensive Care Units.
​Matria Health: Cutting-edge medical devices designed to control and stop postpartum hemorrhage, the leading cause of maternal deaths worldwide. Our innovations ensure patient safety without any biological or chemical side effects.
​Ektah: Therapeutic solutions focused on reducing body weight, aiming to improve health and wellness for each individual dealing with obesity or overweight, helping them to reduce their body weight.
​ZeCardio Therapeutics: Develops targeted therapies for heart disease by focusing on cellular mechanisms that regulate heart function.
​19:10h - 19:15h | Closing Remarks